medigraphic.com
ISSN 1029-3035 (Electronic)

2015, Number 3

<< Back Next >>

Mediciego 2015; 21 (3)

Cardiocirculatory dysfunction in patients with liver cirrhosis

Porbén CN, Camacho AJA, Artigas PR

Language: Spanish
References: 23
Page: 17-26
PDF size: 102.72 Kb.


ABSTRACT

Introduction: the presence of cardiac disturbances in cirrhotic patients has received special attention in these last years.
Objective: to determine the electrocardiographic and echocardiographic disturbances in patients with cirrhosis of the liver attending the Hepatology Doctor´s Office in the University Hospital “Dr. Antonio Luaces Iraola”, as well as its association with the etiology and the prognosis Child-Pugh scoring system.
Method: a cross-sectional observational analytic study was conducted, from May 2012 to May 2014. The universe included 31 patients. All the patients fulfilled the inclusion criteria.
Results: most of the patients were male and were in the “A” stage of the Child-Pugh score. Alcoholism was the most frequent cause of liver cirrhosis. Most of the patients had diastolic dysfunction, but there was not statistically significant relationship among its severity, the Child- Pugh stage and the etiology.
Conclusions: the diastolic diameter of the left ventricle showed statistically significant relationship with the etiology of liver cirrhosis; the diameter of the left atrium, systolic and mean pulmonary artery were statistically related to the Child-Pugh stage. Left atrium enlargement and left ventricle hypertrophy were the most frequent electrocardiographic findings, although no statistical association was observed between them and the etiology of the Child-Pugh stage.


REFERENCES

  1. Berenguer J, Berenguer M, Ponce J, Prieto M. Gastroenterología y Hepatología. España: Elsevier; 2002.

  2. Narro Bobles J, Gutiérrez Ávila J. La mortalidad por cirrosis hepática en México I. Características epidemiológicas relevantes. Rev Salud Mex. 2013;34(4):378-87.

  3. Lebroc Pérez D, Reina Alfonso BE, Camacho Assef JA, Massip Ramírez M. Caracterización clínica de los pacientes con cirrosis hepática en el Hospital Provincial Docente “Dr. Antonio Luaces Iraola”. MediCiego [Internet]. 2011 [citado 12 Dic 2011];17(2):[aprox. 11 p.]. Disponible en: http://bvs.sld.cu/revistas/mciego/vol17_02_2011/articulos/t-6.html

  4. Samada Suárez M. Factores pronósticos de supervivencia en pacientes con cirrosis hepática evaluados para trasplante hepático [tesis]. La Habana: Instituto Superior de Ciencias Médicas de La Habana; 2008.

  5. Ministerio de Salud Pública (Cuba). Anuario Estadístico de Salud 2009 [Internet]. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2009 [citado 12 Jun 2012]. Disponible en: http://files.sld.cu/dne/files/2010/04/anuario-2009e3.pdf

  6. Moller S, Hobolth L, Winkler C, Bendtsen F, Christensen E. Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis. Gut. 2011;60:1254–9.

  7. Kowalski HJ, Abelmann WH. Cardiac output at rest in Laenec’s cirrhosis. J Clin Invest. 1953;32:1025-33.

  8. Signe W, Jens D. Hove, Flemming Bendtsen, Soren Moller. Cirrhotic cardiomyopathy: pathogenesis and clinical relevance. Nature Rev Gastroenterol Hepatol. 2014;(11)3:177–86.

  9. Timoh T, Protano MA, Wagman G, Bloom M, Vittorio TJ. A perspective on cirrhotic cardiomyopathy. Transplant. Proc. 2011;43:1649–53.

  10. Bustíos C, Dávalos M, Román R, Zumaeta E. Características epidemiológicas y clínicas de la cirrosis hepática en la Unidad de Hígado del HNERM. Rev Gastroenterol Perú. 2003;27:238- 45.

  11. Alonso FT, Garmendía ML, De Aguirre M, Searle J. Análisis de la tendencia de la mortalidad por cirrosis hepática en Chile: Años 1990 a 2007. Rev Med Chile [Internet]. 2010 [citado 12 Jul 2013];138(10):1253-8. Disponible en: http://www.scielo.cl/scielo.php?pid=S0034- 98872010001100007&script=sci_arttext&tlng=pt

  12. Hytiroglou P, Snover DC, Alves V, et al. Beyond “cirrhosis”: a proposal from the International Liver Pathology Study Group. Am J Clin Pathol. 2012;137:5-9.

  13. Urdaneta PC, Tovar MY, Feijoo J, Magdaniel J, et al. Prevalencia de la miocardiopatía cirrótica. Rev Gen. 2010;64(4):293-7.

  14. Torre Delgadillo A, Castillo L, Orea A, Rebollar V. Disfunción ventricular en pacientes con cirrosis hepática. Rev Med Int Mex. 2006;22:197-202.

  15. Abarca J, Peña Herrera V, Garcés C, Carrillo L, Sáenz R. Etiología, sobrevida, complicaciones y mortalidad en cirrosis hepática en el Ecuador. Evaluación retrospectiva (1989-2003). Rev Gastr Latinoam. 2006;17(1):29-34.

  16. Pateron D, Ganne N, Trinchet JC, Aurosseau MH, Mal F, Meieler C. Prospective study of screening for hepatocellurar carcinoma in caucasian patients with cirrhosis. J Hepatol. 1994;20:65-71.

  17. Habu D, Shiomi S, Lee C. Trends in the causes and outcome of liver cirrhosis diagnosed by laparoscopy in Osaka, Japan during the post three decades. Digest Endosc. 2001;13:13-6.

  18. Pozzi M, Grassi G, Ratti L, Favini G, Dell' Oro R, Redaelli E, et al. Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child A cirrhosis. Am J Gastroenterol. 2005;100:1110-6.

  19. Finucci G, Desideri A, Sacerdoti D, Bolognesi M, Merkel C, Angeli P, et al. Left ventricular diastolic function in liver cirrhosis. Scand J Gastroenterol. 1996;31:279-84.

  20. Torregrasa, M. Miocardiopatía en el paciente con cirrosis hepática: un trastorno reversible [tesis]. España: Universidad Autónoma de Barcelona; 2004.

  21. Fernández MIC, Marroquín BIR, Martorell FR, Rodríguez IAA, del Vallin SL. Disfunción cardíaca en la cirrosis hepática. Rev Cubana Med [Internet]. 2014 [citado 6 Sep 2014];53(2):189-200. Disponible en: http://scielo.sld.cu/pdf/med/v53n2/med08214.pdf

  22. Zardi EM, Abbate A, Zardi DM, Dobrina A, Margiotta D, Van Tassel BW et al. Cirrhotic cardiomyopathy. J Am College Cardiol [Internet]. 2010 [citado 12 Jul 2013];56(7):539-49. Disponible en: http://content.onlinejacc.org/article.aspx?articleid=1143065

  23. Biazin da Rosa C, Klein MB, Forgiarini Junior LA, Galant LH, Dal Bosco A, Monteiro MB, Marroni CA. Alterações cardíacas e qualidade de vida em doentes hepáticos candidatos ao transplante ortotópico de fígado. Ciência em Movimento-Biociências e Saúde [Internet]. 2012 [citado 12 Ago 2014];13(27):27-33. Disponible en: https://www.metodista.br/revistas/revistasipa/ index.php/EUM/article/viewPDFInterstitial/126/87




2020     |     www.medigraphic.com